Celgene Corporation (NASDAQ:CELG) released on Tuesday that it decided to purcahse Receptos Inc. (RCPT) for around $7.2B in cash. Celgene will take over all of the outstanding shares of Receptos through a wholly-owned subsidiary for $232 a share in cash. The transaction has been permitted by the boards of directors […]